Project: Nano-motion based rapid antimicrobial susceptibility testing to PREVENt sepSIS and fight AMR

Acronym	PREVENSIS (Reference Number: 113912)
Duration	01/06/2020 - 01/06/2023
Project Topic	We will finalise the development of a rapid antimicrobial susceptibility testing diagnostic technology, R-AST, and deliver a device and consumable package ready for CE-IVD mark. R-AST will allow clinicians to prescribe efficient antibiotic therapy for urgent treatment of sepsis. Our approach based on proprietary nano-motion technology to detect bacterial response to antibiotics is significantly faster than current methods therefore enables timely specific treatments to reduce sepsis mortality.
Network	Eurostars 2
Call	Eurostars Cut–off 12

Project partner

Number	Name	Role	Country
1	Amager og Hvidovre Hospital	Partner	Denmark
2	Judex ApS	Partner	Denmark
3	Resistell AG	Coordinator	Switzerland